226 related articles for article (PubMed ID: 29098521)
21. Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy.
Lane AM; Kim IK; Gragoudas ES
JAMA Ophthalmol; 2015 Jul; 133(7):792-6. PubMed ID: 25905597
[TBL] [Abstract][Full Text] [Related]
22. A reappraisal of the significance of largest basal diameter of posterior uveal melanoma.
Damato B; Coupland SE
Eye (Lond); 2009 Dec; 23(12):2152-60; quiz 2161-2. PubMed ID: 19876071
[TBL] [Abstract][Full Text] [Related]
23. Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood.
Naume B; Borgen E; Beiske K; Herstad TK; Ravnås G; Renolen A; Trachsel S; Thrane-Steen K; Funderud S; Kvalheim G
J Hematother; 1997 Apr; 6(2):103-14. PubMed ID: 9131439
[TBL] [Abstract][Full Text] [Related]
24. Detection of bone marrow micrometastasis in gastric cancer patients by immunomagnetic separation.
Matsunami K; Nakamura T; Oguma H; Kitamura Y; Takasaki K
Ann Surg Oncol; 2003 Mar; 10(2):171-5. PubMed ID: 12620913
[TBL] [Abstract][Full Text] [Related]
25. Bone marrow micrometastasis is associated with both disease recurrence and poor survival in surgical patients with node-negative non-small-cell lung cancer: a meta-analysis.
Deng XF; Liu QX; Zhou D; Min JX; Dai JG
Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):21-7. PubMed ID: 25883247
[TBL] [Abstract][Full Text] [Related]
26. Noncontiguous tumor recurrence of posterior uveal melanoma after transscleral local resection.
Kim JW; Damato BE; Hiscott P
Arch Ophthalmol; 2002 Dec; 120(12):1659-64. PubMed ID: 12470139
[TBL] [Abstract][Full Text] [Related]
27. Survival from uveal melanoma in Western Australia 1981-2005.
Chew AL; Spilsbury K; Isaacs TW
Clin Exp Ophthalmol; 2015 Jul; 43(5):422-8. PubMed ID: 25556534
[TBL] [Abstract][Full Text] [Related]
28. Sex Disparity in Survival of Patients With Uveal Melanoma: Better Survival Rates in Women Than in Men in South Korea.
Park SJ; Oh CM; Yeon B; Cho H; Park KH
Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1909-1915. PubMed ID: 28362882
[TBL] [Abstract][Full Text] [Related]
29. Survival of patients and metastatic and local recurrent tumor growth in malignant melanoma of the uvea after ruthenium plaque radiotherapy.
Summanen P; Immonen I; Heikkonen J; Tommila P; Laatikainen L; Tarkkanen A
Ophthalmic Surg; 1993 Feb; 24(2):82-90. PubMed ID: 8446359
[TBL] [Abstract][Full Text] [Related]
30. Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation.
Naume B; Borgen E; Nesland JM; Beiske K; Gilen E; Renolen A; Ravnås G; Qvist H; Kåresen R; Kvalheim G
Int J Cancer; 1998 Nov; 78(5):556-60. PubMed ID: 9808522
[TBL] [Abstract][Full Text] [Related]
31. Immunomagnetic separation for enrichment and sensitive detection of disseminated tumour cells in patients with head and neck SCC.
Partridge M; Phillips E; Francis R; Li SR
J Pathol; 1999 Nov; 189(3):368-77. PubMed ID: 10547599
[TBL] [Abstract][Full Text] [Related]
32. Retrospective evaluation of patients with uveal melanoma treated by stereotactic radiosurgery with and without tumor resection.
Suesskind D; Scheiderbauer J; Buchgeister M; Partsch M; Budach W; Bartz-Schmidt KU; Ritz R; Grisanti S; Paulsen F
JAMA Ophthalmol; 2013 May; 131(5):630-7. PubMed ID: 23494018
[TBL] [Abstract][Full Text] [Related]
33. Bi-specific immunomagnetic enrichment of micrometastatic tumour cell clusters from bone marrow of cancer patients.
Woelfle U; Breit E; Zafrakas K; Otte M; Schubert F; Müller V; Izbicki JR; Löning T; Pantel K
J Immunol Methods; 2005 May; 300(1-2):136-45. PubMed ID: 15907331
[TBL] [Abstract][Full Text] [Related]
34. Detection of bone marrow micrometastasis in esophageal cancer patients by immunomagnetic separation.
Nakamura T; Matsunami K; Hayashi K; Ota M; Ide H; Takasaki K
Oncol Rep; 2004 May; 11(5):999-1003. PubMed ID: 15069538
[TBL] [Abstract][Full Text] [Related]
35. Identification of circulating melanoma cells in uveal melanoma patients by dual-marker immunoenrichment.
Tura A; Lüke J; Merz H; Reinsberg M; Lüke M; Jager MJ; Grisanti S
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4395-404. PubMed ID: 24970258
[TBL] [Abstract][Full Text] [Related]
36. Circulating tumor cells in uveal melanoma.
Torres V; Triozzi P; Eng C; Tubbs R; Schoenfiled L; Crabb JW; Saunthararajah Y; Singh AD
Future Oncol; 2011 Jan; 7(1):101-9. PubMed ID: 21174541
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of cytokeratin positive cells in bone marrow of gastric cancer patients.
Oki E; Kakeji Y; Baba H; Nishida K; Koga T; Tokunaga E; Egashira A; Ikeda K; Yoshida R; Yamamoto M; Morita M; Maehara Y
J Cancer Res Clin Oncol; 2007 Dec; 133(12):995-1000. PubMed ID: 17588173
[TBL] [Abstract][Full Text] [Related]
38. Presence of bone marrow micro-metastases in stage I-III colon cancer patients is associated with worse disease-free and overall survival.
Viehl CT; Weixler B; Guller U; Dell-Kuster S; Rosenthal R; Ramser M; Banz V; Langer I; Terracciano L; Sauter G; Oertli D; Zuber M
Cancer Med; 2017 May; 6(5):918-927. PubMed ID: 28401701
[TBL] [Abstract][Full Text] [Related]
39. Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients.
Gilje B; Nordgård O; Tjensvoll K; Janssen EA; Søiland H; Smaaland R; Baak JP
Breast Cancer Res Treat; 2011 Jul; 128(1):137-46. PubMed ID: 21476002
[TBL] [Abstract][Full Text] [Related]
40. Prognostic relevance of ATM protein in uveal melanoma and its association with clinicopathological factors.
Jha J; Singh MK; Singh L; Pushker N; Bajaj MS; Sen S; Kashyap S
Int J Clin Oncol; 2019 Dec; 24(12):1526-1535. PubMed ID: 31377937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
